37th Annual New Treatments in Chronic Liver Disease CME Conference

This conference will review the latest medications and therapies in liver treatment and transplantation. The results of trials and real-world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.

URL:
Tickets: https://go.evvnt.com/1407701-0?pid=176

Prices:
Physicians (MD, DO, MBBS): USD 350.00,
RN, NP, PA, Other: USD 300.00,
Students, Residents, Fellows: USD 175.00

Speakers: Paul J. Pockros, MD, FACG, Julio A. Gutierrez, MD, Adam Deising, DO, Kris V. Kowdley, MD, FACP, FACG, FASGE, AGAF, FAASLD, Rohit Loomba, MD, Michael Schilsky, MD, Amit Singal, MD, Florence Wong, MD, Florence Wong, MD, Robert Gish, MD

Time: 8:00 am to 12:00 pm